Professor Thomas D. Szucs, MPH, LLM, MBA, has been the Chair of the Board of Directors of the Helsana Group since 2010 and, in this capacity, also serves as Chair of the Executive, Compensation and Nomination Committee, as well as Chair of the Investment Committee and as a member of the Digitalization Committee.
Thomas D. Szucs is Professor and Director of the European Center of Pharmaceutical Medicine at the University of Basel. He practises personalised medicine at the Klinik Hirslanden and helps to develop genomic medicine at the Hirslanden Group. His research and teaching focuses on the areas of pharmacoeconomics, pharmaceutical policy, healthcare provision and health technology evaluation. Previously, he led the Department of Medical Economics at the University of Zurich’s Institute for Social and Preventive Medicine, and he has worked in the following roles, among others: founder and Head of Research at the Centre for Pharmacoeconomics at the University of Milan; Head of the Working Group on Clinical Economics at the University of Munich; Senior Consultant at Arthur D. Little, Inc. and Head of the Department of Health Economics at F. Hoffmann-La Roche AG in Basel. He is also a member of the editorial board of various scientific journals.
After completing a medical degree and a doctorate at the University of Basel, Thomas D. Szucs attained a Master’s in Business Management from the University of St. Gallen, a Master of Public Health from Harvard University, an LL.M. in International Business Law from the University of Zurich and a Doctorate in Law from the Private University of the Principality of Liechtenstein. In 2010 he was named an honorary professor at Peking University’s Health Science Centre. He is a specialist in pharmaceutical medicine, prevention and public health.
Other activities and mandates:
We're here to help.